Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of actinic keratosis in transplant recipients
NL-OMON25323Suspended
- Sponsor
- Erasmus MC
- Start
- Jul 2013
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in actinic keratosis (AK) comparing Methyl aminolevulinate PDT versus 5-fluorouracil with Methyl aminolevulinate PDT versus imiquimod (2 arms). Primary endpoint: Patient preference. Started Jul 2013; status: suspended.
02
Drugs
methyl aminolevulinatefluorouracilimiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NL-OMON25323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25323.